Today, we pause to honor the courage, sacrifice, and unwavering dedication of our veterans. To all who have served—thank you for protecting our freedom and inspiring us with your strength. Your service will never be forgotten. #VeteransDay #ThankYouVeterans #HonorAndRespect

Get to Know - Zuhal Reed, ESQ., Sr. Staff Attorney #LifeSciences Risk Management - She will be presenting this week on "Ripped from the Headlines: A Look Back on 2025". Register Now: https://t.co/QbXeNRZpTL

Get to Know - Kate Klaus, Sr. Attorney #RiskManagement - #FDA Specialist for @MedmarcIns - She will be presenting next week on "Ripped from the Headlines: A Look Back on 2025". Register Now: https://t.co/Ogilvtrs3O

We are excited to see you in 2 weeks in San Diego for the @MedTechStrat Innovation Summit! Be sure to connect with Lynn Carney. #InnovationSanDiego https://t.co/U2Pd6ewhI3

@AdvaMedUpdate Read more:

[Blog] The U.S. Department of Commerce is investigating national security risks in trade, impacting #MedicalDevices. @AdvaMedUpdate warns tariffs could disrupt the industry and urges the White House to support policies that enhance #MedTech competitiveness and patient access.

November 12-13, John Ajello will be representing Medmarc at the 2025 Together ’25 @LifeSciNY Annual Conference in Syracuse, NY. There will be a tour of @inspyre_hub and panels on investments in NY State’s #medtech community. #MakingHealthBetterTogether https://t.co/CGbT4gZF7v

#HappyHalloween! We hope you have a safe, fun, and spooky day! 👻

Grateful to everyone who joined our Annual Broker Meeting in Las Vegas this September. Your engagement made it a success! We're dedicated to protecting #MedTech & #LifeSciences companies with specialized #ProductLiability ins. for industry-specific risks. https://t.co/yDH9UZbU6H

Learn more:

New Blog: #FDA's final guidance on PCCPs, alongside international principles, gives #AI device manufacturers a clearer regulatory path. As AI devices evolve, manufacturers must communicate new risks and be ready to address liability if updates result in patient harm.

#TipTuesday: #MedicalDevice sales representatives must quickly report adverse events to the #FDA to ensure compliance and #PatientSafety. Know what constitutes an adverse event! 🗒️ https://t.co/dLOKBUTUsb

Did you miss this week's webinar or want to rewatch a section? You can watch now on Medmarc's YouTube channel - Are you following us there?? Watch now: https://t.co/XETlyq8VYv

#TipTuesday: Manufacturers must warn consumers about product risks even after sale. Staying informed is a legal duty! Create a post-sale management program to ensure safety and build trust. https://t.co/TMRZaMAZkq

Reminder - we have our #RiskManagement webinar this week! Tony Freeman will discuss "State of the Medtech Industry". Are you registered? https://t.co/Sirh8Eqn0r

In 2025, #MedicalDevice and #LifeSciences manufacturers must navigate complex supply chain challenges—driven by shifting regulations, global events, & rising cyber risks. Is your org ready to protect its operations and maintain patient care? Learn more:

Zuhal Reed talks about "Navigating Duty-to-Warn Challenges in Biotech #ClinicalTrials" in a post for @pharmasalmanac. This paper examines how biotech liability heightens the duty to warn and how a robust consent process lessens sponsor exposure. Read more: https://t.co/C4xNhFMugW

Get to know - Tony Freeman, President of A.S. Freeman Advisors LLC - He will be joining us next week, 10/15 for our #RiskManagement Webinar Series. Register Now: https://t.co/mxoVchq7Ct

#TipTuesday - Under the Learned Intermediary Doctrine, manufacturers aren't legally required to warn consumers of harmful side effects if disclosed to a "learned intermediary." Learn more about the warnings➡️ https://t.co/w6mE922LWC

The Medmarc team is here #MTC25 at booth 1016! Let’s talk about your medical innovations and #LifeSciences Insurance ✅